Network Pharmacology-Based Prediction of Active Ingredients and Mechanisms of Lamiophlomis rotata (Benth.) Kudo Against Rheumatoid Arthritis

Background: Lamiophlomis rotata (LR) showed favorable clinical effect and safety on rheumatoid arthritis (RA), but its active ingredients and mechanisms against RA remain unknown. The aim of this work was to explore the active ingredients and mechanisms of LR against RA by network pharmacology. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yunbin, Zhong, Mei, Long, Fei, Yang, Rongping, Zhang, Yanfei, Liu, Tonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902022/
https://www.ncbi.nlm.nih.gov/pubmed/31849678
http://dx.doi.org/10.3389/fphar.2019.01435
_version_ 1783477607656849408
author Jiang, Yunbin
Zhong, Mei
Long, Fei
Yang, Rongping
Zhang, Yanfei
Liu, Tonghua
author_facet Jiang, Yunbin
Zhong, Mei
Long, Fei
Yang, Rongping
Zhang, Yanfei
Liu, Tonghua
author_sort Jiang, Yunbin
collection PubMed
description Background: Lamiophlomis rotata (LR) showed favorable clinical effect and safety on rheumatoid arthritis (RA), but its active ingredients and mechanisms against RA remain unknown. The aim of this work was to explore the active ingredients and mechanisms of LR against RA by network pharmacology. Methods: Compounds from LR were identified using literature retrieval and screened by absorption, distribution, metabolism, excretion, and toxicity (ADMET) evaluation. Genes related to the selected compounds or RA were identified using public databases, and the overlapping genes between compounds and RA target genes were identified using Venn diagram. Then, the interactions network between compounds and overlapping genes was constructed, visualized, and analyzed by Cytoscape software. Finally, pathway enrichment analysis of overlapping genes was carried out on Database for Annotation, Visualization, and Integrated Discovery (DAVID) platform. Results: A total of 148 compounds in LR were identified, and ADMET screen results indicated that 67 compounds exhibited good potential as active ingredients. A total of 90 compounds-related genes and 1,871 RA-related genes were identified using public databases, and 48 overlapping genes between them were identified. Cytoscape results suggested that the active ingredients and target genes of LR against RA consisted of 23 compounds and 48 genes, and luteolin and AKT1 were the uppermost active ingredient and hub gene, respectively. DAVID results exhibited that the mechanisms of LR against RA were related to 34 signaling pathways, and the key mechanism of LR against RA might be to induce apoptosis of synovial cells by inactivating PI3K-Akt signaling pathway. Conclusion: The active ingredients and mechanisms of LR against RA were firstly investigated using network pharmacology. This work provides scientific evidence to support the clinical effect of LR on RA, and a research basis for further expounding the active ingredients and mechanisms of LR against RA.
format Online
Article
Text
id pubmed-6902022
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69020222019-12-17 Network Pharmacology-Based Prediction of Active Ingredients and Mechanisms of Lamiophlomis rotata (Benth.) Kudo Against Rheumatoid Arthritis Jiang, Yunbin Zhong, Mei Long, Fei Yang, Rongping Zhang, Yanfei Liu, Tonghua Front Pharmacol Pharmacology Background: Lamiophlomis rotata (LR) showed favorable clinical effect and safety on rheumatoid arthritis (RA), but its active ingredients and mechanisms against RA remain unknown. The aim of this work was to explore the active ingredients and mechanisms of LR against RA by network pharmacology. Methods: Compounds from LR were identified using literature retrieval and screened by absorption, distribution, metabolism, excretion, and toxicity (ADMET) evaluation. Genes related to the selected compounds or RA were identified using public databases, and the overlapping genes between compounds and RA target genes were identified using Venn diagram. Then, the interactions network between compounds and overlapping genes was constructed, visualized, and analyzed by Cytoscape software. Finally, pathway enrichment analysis of overlapping genes was carried out on Database for Annotation, Visualization, and Integrated Discovery (DAVID) platform. Results: A total of 148 compounds in LR were identified, and ADMET screen results indicated that 67 compounds exhibited good potential as active ingredients. A total of 90 compounds-related genes and 1,871 RA-related genes were identified using public databases, and 48 overlapping genes between them were identified. Cytoscape results suggested that the active ingredients and target genes of LR against RA consisted of 23 compounds and 48 genes, and luteolin and AKT1 were the uppermost active ingredient and hub gene, respectively. DAVID results exhibited that the mechanisms of LR against RA were related to 34 signaling pathways, and the key mechanism of LR against RA might be to induce apoptosis of synovial cells by inactivating PI3K-Akt signaling pathway. Conclusion: The active ingredients and mechanisms of LR against RA were firstly investigated using network pharmacology. This work provides scientific evidence to support the clinical effect of LR on RA, and a research basis for further expounding the active ingredients and mechanisms of LR against RA. Frontiers Media S.A. 2019-11-27 /pmc/articles/PMC6902022/ /pubmed/31849678 http://dx.doi.org/10.3389/fphar.2019.01435 Text en Copyright © 2019 Jiang, Zhong, Long, Yang, Zhang and Liu http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Jiang, Yunbin
Zhong, Mei
Long, Fei
Yang, Rongping
Zhang, Yanfei
Liu, Tonghua
Network Pharmacology-Based Prediction of Active Ingredients and Mechanisms of Lamiophlomis rotata (Benth.) Kudo Against Rheumatoid Arthritis
title Network Pharmacology-Based Prediction of Active Ingredients and Mechanisms of Lamiophlomis rotata (Benth.) Kudo Against Rheumatoid Arthritis
title_full Network Pharmacology-Based Prediction of Active Ingredients and Mechanisms of Lamiophlomis rotata (Benth.) Kudo Against Rheumatoid Arthritis
title_fullStr Network Pharmacology-Based Prediction of Active Ingredients and Mechanisms of Lamiophlomis rotata (Benth.) Kudo Against Rheumatoid Arthritis
title_full_unstemmed Network Pharmacology-Based Prediction of Active Ingredients and Mechanisms of Lamiophlomis rotata (Benth.) Kudo Against Rheumatoid Arthritis
title_short Network Pharmacology-Based Prediction of Active Ingredients and Mechanisms of Lamiophlomis rotata (Benth.) Kudo Against Rheumatoid Arthritis
title_sort network pharmacology-based prediction of active ingredients and mechanisms of lamiophlomis rotata (benth.) kudo against rheumatoid arthritis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902022/
https://www.ncbi.nlm.nih.gov/pubmed/31849678
http://dx.doi.org/10.3389/fphar.2019.01435
work_keys_str_mv AT jiangyunbin networkpharmacologybasedpredictionofactiveingredientsandmechanismsoflamiophlomisrotatabenthkudoagainstrheumatoidarthritis
AT zhongmei networkpharmacologybasedpredictionofactiveingredientsandmechanismsoflamiophlomisrotatabenthkudoagainstrheumatoidarthritis
AT longfei networkpharmacologybasedpredictionofactiveingredientsandmechanismsoflamiophlomisrotatabenthkudoagainstrheumatoidarthritis
AT yangrongping networkpharmacologybasedpredictionofactiveingredientsandmechanismsoflamiophlomisrotatabenthkudoagainstrheumatoidarthritis
AT zhangyanfei networkpharmacologybasedpredictionofactiveingredientsandmechanismsoflamiophlomisrotatabenthkudoagainstrheumatoidarthritis
AT liutonghua networkpharmacologybasedpredictionofactiveingredientsandmechanismsoflamiophlomisrotatabenthkudoagainstrheumatoidarthritis